To direct the Secretary of Defense to report on illicit drug use and overdoses by members of the Armed Forces serving on active duty.

Bill: 118-hr-5731
Sponsor: full_name: Rep. Ryan, Patrick [D-NY-18]
Introduced: 2023-09-26
Policy area: Armed Forces and National Security
Latest action: action_date: 2023-09-26
text: Referred to the House Committee on Armed Services.

Summaries:
action_date: 2023-09-26
action_desc: Introduced in House
text: <p>This bill requires the Department of Defense (DOD) to report on illicit drug use by members of the Armed Forces serving on active duty and the monitoring and prevention systems within DOD regarding such use. The report must be submitted not later than December 1, 2023.</p>

tv_txt: I 118th CONGRESS 1st Session H. R. 5731 IN THE HOUSE OF REPRESENTATIVES September 26, 2023 Mr. Ryan introduced the following bill; which was referred to the Committee on Armed Services A BILL To direct the Secretary of Defense to report on illicit drug use and overdoses by members of the Armed Forces serving on active duty.

1. Report on illicit drug use and overdoses by members of the Armed Forces serving on active duty Not later than December 1, 2023, the Secretary of Defense shall submit to the Committees on Armed Services of the Senate and House of Representatives a report regarding illicit drug use by members of the Armed Forces serving on active duty, and monitoring and prevention systems within the Department of Defense regarding such use. The report shall include the following elements: (1) The number of instances of such drug use and overdoses among such members during the calendar year preceding the date of the report. (2) The number of instances described in paragraph (1) that were related to fentanyl. (3) An explanation of how the Secretary uses urinalysis and other tests to monitor such use, and an assessment of the efficacy of such tests. (4) The extent to which fentanyl has contributed to such overdoses when combined with other, less deadly substances. (5) The policies of the Department designed to prevent retaliation against such members who seek treatment or inform a commanding officer of their illicit drug use. (6) Demographic data and ranks of such members who suffered a fentanyl overdose. (7) Shortcomings (including strategic or budgetary) identified by the Secretary of the counternarcotics programs of the Department regarding military installations. (8) A thorough review of the support and treatment options offered to such a member who reports addiction or illicit drug use, including— (A) any wait time before receiving care; and (B) the type of care offered across each Armed Force. (9) Any other matter the Secretary determines appropriate.